The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Abbvie; Janssen; Pharmacyclics

Final analysis from RESONATE: Six-year follow-up in patients (pts) with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) on ibrutinib.
 
Paul M. Barr
Consulting or Advisory Role - Abbvie; Celgene; Genentech; Infinity Pharmaceuticals; Janssen; Merck; Novartis; Pharmacyclics; Seagen; TG Therapeutics
Research Funding - Pharmacyclics (Inst)
 
Talha Munir
Honoraria - Abbvie; Alexion Pharmaceuticals; Gilead Sciences; Janssen; Novartis
Consulting or Advisory Role - MorphoSys
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; Janssen
 
Jennifer R. Brown
Honoraria - Abbvie; Janssen Oncology
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Celgene; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics; Redx Pharma; Roche/Genentech; Sun Pharma
Research Funding - Gilead Sciences
 
Susan Mary O'Brien
Employment - University of California, Irvine
Honoraria - Abbvie; Alexion Pharmaceuticals; Amgen; Aptose Biosciences; Astellas Pharma; Celgene; Eisai; Gilead Sciences; GlaxoSmithKline; Janssen; Loxo; Pfizer; Pharmacyclics; Sunesis Pharmaceuticals; TG Therapeutics; Vaniam Group
Consulting or Advisory Role - Abbvie/Genentech; Alexion Pharmaceuticals; Amgen; Aptose Biosciences; Astellas Pharma; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Pfizer; Pharmacyclics; Sunesis Pharmaceuticals; Sunesis Pharmaceuticals; TG Therapeutics; Vaniam Group
Research Funding - Acerta Pharma (Inst); Gilead Sciences (Inst); Kite, a Gilead company (Inst); Pfizer (Inst); Pharmacyclics (Inst); Regeneron (Inst); Sunesis Pharmaceuticals (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; Janssen; Janssen Oncology; Regeneron
 
Jacqueline Claudia Barrientos
Honoraria - Janssen
Consulting or Advisory Role - Abbvie; Bayer; Genentech; Gilead Sciences; Pharmacyclics
Research Funding - Pharmacyclics (Inst)
Travel, Accommodations, Expenses - Janssen
 
Nishitha M. Reddy
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Bristol-Myers Squibb; Celgene
Speakers' Bureau - Gilead Sciences
Research Funding - Bristol-Myers Squibb (Inst)
 
Steven Coutre
Stock and Other Ownership Interests - Pharmacyclics (I)
Consulting or Advisory Role - Abbvie; BeiGene; Celgene; Genentech/Roche; Gilead Sciences; Janssen Oncology; Novartis; Pharmacyclics
Research Funding - Abbvie (Inst); Acerta Pharma/AstraZeneca (Inst); Celgene (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Millenium Pharamceuticals (Inst); Pharmacyclics (Inst)
Travel, Accommodations, Expenses - abbvie; BeiGene; Celgene; Gilead Sciences; Janssen Oncology; Novartis; Pharmacyclics
 
Constantine Si Lun Tam
Honoraria - Abbvie; Beigene; Janssen-Cilag; Novartis; Pharmacyclics
Research Funding - Abbvie (Inst); Janssen-Cilag (Inst)
 
Stephen P. Mulligan
Honoraria - Abbvie; Gilead Sciences; GlaxoSmithKline; Janssen; Roche
Consulting or Advisory Role - Abbvie; Gilead Sciences; GlaxoSmithKline; Janssen; Roche
Speakers' Bureau - Abbvie; Gilead Sciences; Janssen; Roche
Research Funding - Abbvie; Janssen; Roche
 
Ulrich Jäger
Honoraria - Abbvie; Amgen; AOP Orphan Pharmaceuticals; Bioverativ; Bristol-Myers Squibb; Celgene; Emergent BioSolutions; Gilead Sciences; Janssen-Cilag; Mundipharma; Novartis; Roche; Sandoz; Takeda; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Gilead Sciences; Novartis; Roche
Research Funding - Abbvie (Inst); Bioverativ (Inst); Celgene (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Janssen-Cilag (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
 
Thomas J. Kipps
Employment - Moores Cancer Center
Honoraria - Pharmacyclics/ AbbVie/ Janssen/ Celgene/Genentech/ Roche/ Gilead/ Dava Oncology
Consulting or Advisory Role - AbbVie/ Pharmacyclics/ Celgene/ Genentech/ Roche/ Leukemia / Janssen/ Dava Oncology/ Gilead
Speakers' Bureau - Verastem/Pharmacyclics
Travel, Accommodations, Expenses - Travel/ Honoraria covered by the companies below
 
Carol Moreno
No Relationships to Disclose
 
Marco Montillo
Honoraria - Abbvie; Gilead Sciences; Janssen; Roche
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen; Roche
Speakers' Bureau - Abbvie; Gilead Sciences; Janssen
Research Funding - Roche
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; Janssen; Roche
 
Jan Andreas Burger
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics; Pharmacyclics; Pharmacyclics
Research Funding - Celgene (Inst); Gilead Sciences (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
John C. Byrd
Consulting or Advisory Role - Acerta Pharma; Genentech; Jazz Pharmaceuticals; Pharmacyclics
Research Funding - Acerta Pharma (Inst); Genentech (Inst); Janssen (Inst); Pharmacyclics (Inst)
 
Peter Hillmen
Honoraria - Abbvie; Janssen; Roche
Research Funding - Gilead Sciences (Inst); Janssen (Inst); Pharmacyclics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Abbvie; Janssen
 
Sandra Dai
Employment - Pharmacyclics
Stock and Other Ownership Interests - Abbvie
 
Anita Szoke
Employment - Pharmacyclics
Stock and Other Ownership Interests - Abbvie
 
James P. Dean
Employment - CTI; Pharmacyclics
Stock and Other Ownership Interests - Abbvie; CTI
 
Jennifer Ann Woyach
Research Funding - Abbvie; Acerta Pharma; Janssen; Karyopharm Therapeutics; MorphoSys